In a report released today, Serge Belanger from Needham maintained a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report). The company's shares closed last Monday at $31.76. According to TipRanks.com, Belanger 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -3.6% and a 35.6% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Clarus Therapeutics Holdings, Collegium Pharmaceutical, and KalVista Pharmaceuticals. Currently, the analyst consensus on Amphastar Pharmaceuticals is a Moderate Buy with an average price target of $38.75. See today’s best-performing stocks on TipRanks >> The company has a one-year high of $44.
https://www.tipranks.com/news/blurbs/needham-sticks-to-its-hold-rating-for-amphastar-pharmaceuticals-amph?utm_source=advfn.com&utm_medium=referral
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Amphastar Pharmaceuticals Charts.
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Amphastar Pharmaceuticals Charts.